News & Articles

Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System

University of Sheffield scientists discover nine novel genes for osteoarthritis

From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology

A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests

How research at the AMR Centre, UK, is accelerating the fight against antimicrobial resistance

Discover 10 wonderful webinars popular with scientists across the globe in 2017 — and watch them on demand

Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth

Polymer surface grafting of anti-bacterial copper nanoparticles could reduce spread of infections and viruses

An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust

Testing at the point-of-care improves patient care with results in less than a minute

Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing

Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix

Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease

Read exclusive interviews from experts in healthcare settings around the world, to discover how mass spectrometry is improving clinical diagnostics

Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research

Gyrolab Generic TK Kit for early-stage biotherapeutic development

Stanford researchers have developed a reliable, hassle-free HIV test ideal for screen large numbers of people and heading off potential outbreaks